Sly Saint
Senior Member (Voting Rights)
Received: 6 February 2020; Accepted: 6 February 2020; Published: 8 February 2020
pdf
https://www.google.com/url?sa=t&rct=j&q=&esrc=s&source=web&cd=12&cad=rja&uact=8&ved=2ahUKEwj9zaGR2cTnAhVkTxUIHY_WDHsQFjALegQICRAB&url=https%3A%2F%2Fwww.mdpi.com%2F2075-4418%2F10%2F2%2F92%2Fpdf&usg=AOvVaw16MD1oWAA1bFfY8Z2bNh--
eta: journal link
https://www.mdpi.com/2075-4418/10/2/92
It is well known that myalgic encephalomyelitis (ME) and chronic fatigue syndrome (CFS), whether considered as separate diseases or as the one chronic syndrome, continue to generate debate. Discussions on language, definitions and theoretical parameters continue, but whatever your position, one can now agree that ME and/or CFS (referred to hereafter as ME/CFS) is a disease with a physiological basis, rooted in biochemical and molecular dysfunction in the cells of sick individuals, and not attitudes that can be alleviated by psychological therapies.
As a result, biomedical imperatives must now become the focus of research enquiry in order to find clinically translatable answers as soon as possible.
This book is intended as a landmark volume to mark this shift in thinking and to consolidate recent fundamental discoveries and biomedical insights as pathways towards tangible diagnostics, and eventual ME/CFS treatments. Australian researchers, with their collaborators locally and abroad, have been at the forefront of discovery in the biomedical realm, and this book draws together fundamental and applied insights that have emerged from scientific and clinical enquiry.
The consolidation of up-to-date insights into ME/CFS was catalysed by a conference (https://www.emerge.org.au/symposium#.XbIv2iVS-3c) in March 2019 (Geelong, Australia), hosted by Emerge Australia, and several chapters in this volume are based on presentations from this meeting.
Biomedical Insights that Inform the Diagnosis of ME/CFS - MDPIConcluding Remarks
To reiterate, this book, as a Special Issue of the MDPI journal Diagnostics, stands as a landmark to consolidate the extent and value of biomedical research into ME/CFS, and associated clinical observations. Another metaphor may be a “rallying point”, especially for those who have accepted the physiological basis of ME/CFS, but have been discouraged by ongoing disagreement among the research community and health professionals. In spite of debate, the evidence presented here and elsewhere provides sufficient impetus to explore ME/CFS as a biomedical challenge that can be solved.
Guided by the journal title, all contributors were encouraged to focus on elements within their research or practice that emphasised diagnostic utility and innovation. Having succeeded in presenting a collection of manuscripts spanning patient experience to pathology, physiology to molecular and cellular biology, we hope that this publication invites further insights from biomedical science, and finally acceptance that ME/CFS is a true disease with physiological foundations.
https://www.google.com/url?sa=t&rct=j&q=&esrc=s&source=web&cd=12&cad=rja&uact=8&ved=2ahUKEwj9zaGR2cTnAhVkTxUIHY_WDHsQFjALegQICRAB&url=https%3A%2F%2Fwww.mdpi.com%2F2075-4418%2F10%2F2%2F92%2Fpdf&usg=AOvVaw16MD1oWAA1bFfY8Z2bNh--
eta: journal link
https://www.mdpi.com/2075-4418/10/2/92
Last edited: